These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1008988)
61. Retrobulbar neuritis. In vitro evidence of sensitization to myelin basic protein in patients without multiple sclerosis. Sheremata W; Younge B; Eylar EH Neurology; 1977 Jun; 27(6):557-60. PubMed ID: 559264 [TBL] [Abstract][Full Text] [Related]
62. [Macrophage electrophoresis mobility test (MEM) in patients with tumors of the oral cavity and controls. Cross sectional study]. Metzner G; Hyckel P; Haroske D; Müller P Zahn Mund Kieferheilkd Zentralbl; 1982; 70(5):465-71. PubMed ID: 6216685 [No Abstract] [Full Text] [Related]
63. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis. Sheremata W; Triller H; Cosgrove JB; Eylar EH Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161 [TBL] [Abstract][Full Text] [Related]
64. In vivo and in vitro cell-mediated immune reactions to auto-chthonous tumor extracts in patients with gastric cancer. Nakajima T; Gonmori M; Isojima K; Iwaguchi T Gan; 1976 Aug; 67(4):537-47. PubMed ID: 1024851 [TBL] [Abstract][Full Text] [Related]
65. [Cross-reactivity of 3M KCl extracts of fetal tissue from various species in the macrophage electrophoresis mobility (MEM) test. I. Extracts from fetuses of mammals and one species of fowl]. Schlott B; Gryschek G; Reinhöfer J; von Broen B; Pasternak G Arch Geschwulstforsch; 1983; 53(2):93-8. PubMed ID: 6344836 [TBL] [Abstract][Full Text] [Related]
66. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells. Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742 [TBL] [Abstract][Full Text] [Related]
67. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors]. Schlott B; Gryschek G; Albrecht S; Pasternak G Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925 [TBL] [Abstract][Full Text] [Related]
68. [Experiences with the electrophoretic mobility test in children. A diagnostic help in pediatric oncology? (author's transl)]. Ritter J; Oehme J Monatsschr Kinderheilkd (1902); 1978 Sep; 126(9):556-60. PubMed ID: 80743 [TBL] [Abstract][Full Text] [Related]
70. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)]. Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724 [TBL] [Abstract][Full Text] [Related]
71. Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected data. Kast RE Med Hypotheses; 1980 Jan; 6(1):63-72. PubMed ID: 6155596 [TBL] [Abstract][Full Text] [Related]
72. Differences of the in vitro reactivity of lymphocytes from normal and persistently lymphocytotic cows to enzootic bovine leukosis tumour membrane extracts as detected with the macrophage-electrophoretic mobility test. Ristau E; Schlott B; Gryschek G; Wittmann W Acta Biol Med Ger; 1982; 41(7-8):705-13. PubMed ID: 7148278 [TBL] [Abstract][Full Text] [Related]
73. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Zhang Y; Burger D; Saruhan G; Jeannet M; Steck AJ Neurology; 1993 Feb; 43(2):403-7. PubMed ID: 7679782 [TBL] [Abstract][Full Text] [Related]
74. Interaction of myelin basic protein with mononuclear cells: the primary reaction for the MEM and EMT tests. Goppelt M; Grol M; Pingoud A; Schumacher K Br J Cancer; 1981 Dec; 44(6):838-45. PubMed ID: 6173054 [TBL] [Abstract][Full Text] [Related]
75. The linoleic acid depression (LAD) test for multiple sclerosis using the macrophage electrophoretic mobility (MEM) test. Jenssen HL; Meyer-Rienecker HJ; Köhler H; Günther JK Acta Neurol Scand; 1976 Jan; 53(1):51-60. PubMed ID: 1251680 [TBL] [Abstract][Full Text] [Related]
76. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis. A longitudinal study employing direct buffy coat migration inhibition assays. Lisak RP; Zweiman B; Waters D; Korpowski H; Pleasure DE Neurology; 1978 Aug; 28(8):798-803. PubMed ID: 567297 [TBL] [Abstract][Full Text] [Related]
77. [Demonstration and characterization of tumor-associated antigenic components from cell membranes of a UV-induced murine sarcoma using the MEM technic]. Ristau E; Schön R; Schlott B; von Broen B Acta Biol Med Ger; 1980; 39(2-3):315-25. PubMed ID: 7424350 [TBL] [Abstract][Full Text] [Related]
78. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration]. Metzner G; Jäger L Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821 [TBL] [Abstract][Full Text] [Related]
79. Application of the macrophage migration inhibition test to screen patients with early cancer and obtain prognostic determinations of cancer treatment. Akiyama T; Yamura N Jpn J Microbiol; 1976 Apr; 20(2):131-40. PubMed ID: 948144 [TBL] [Abstract][Full Text] [Related]
80. Macrophage electrophoretic mobility test for brain tumors and malignancies. Yongde S; Zhensheng T; Chuanshen L; Baoguo X; Zijun L; Yifei S; Yanfang J; Xindi Y; Meizhen L; Xuezhen S Chin Med J (Engl); 1979 Mar; 92(3):211-5. PubMed ID: 109261 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]